The microbiome data holds a vault that could reshape the future of medicine.
In this episode, we sit down with Mr. Kumar Shakaran, CEO of Leucine Rich Bio, to talk about how gut microbiome sequencing is changing the game—making disease prediction and personalized treatments a real possibility. We get into the challenges, the breakthroughs, and what’s next for microbiome-driven medicine.
Tune in now.
